These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 16190134)

  • 61. [Prevention of meningococcal infection].
    Campos J
    Enferm Infecc Microbiol Clin; 1990 Apr; 8(4):193-5. PubMed ID: 2128606
    [No Abstract]   [Full Text] [Related]  

  • 62. Meningococcal disease in students at the University of Southampton: update.
    Commun Dis Rep CDR Wkly; 1997 Nov; 7(45):401. PubMed ID: 9401188
    [No Abstract]   [Full Text] [Related]  

  • 63. Group-specific meningococcal vaccination and epidemics caused by other groups of meningococci.
    Mäkelä PH; Peltola H
    Lancet; 1978 Oct; 2(8093):780-1. PubMed ID: 80699
    [No Abstract]   [Full Text] [Related]  

  • 64. Meningococcal disease in Ironville.
    Commun Dis Rep CDR Wkly; 1999 Aug; 9(34):297. PubMed ID: 10502876
    [No Abstract]   [Full Text] [Related]  

  • 65. Risk for meningococcal disease associated with the Hajj 2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Feb; 50(6):97-8. PubMed ID: 11263795
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Estimating costs associated with a community outbreak of meningococcal disease in a colombian Caribbean city.
    Pinzón-Redondo H; Coronell-Rodriguez W; Díaz-Martinez I; Guzmán-Corena A; Constenla D; Alvis-Guzmán N
    J Health Popul Nutr; 2014 Sep; 32(3):539-48. PubMed ID: 25395916
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Update: assessment of risk for meningococcal disease associated with the Hajj 2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Mar; 50(12):221-2. PubMed ID: 11300626
    [TBL] [Abstract][Full Text] [Related]  

  • 68. An Overview of Neisseria meningitidis.
    Hollingshead S; Tang CM
    Methods Mol Biol; 2019; 1969():1-16. PubMed ID: 30877666
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Meningococcal disease prevention and control strategies for practice-based physicians. Committee on Infectious Diseases, American Academy of Pediatrics. Infectious Diseases and Immunization Committee, Canadian Paediatric Society.
    Pediatrics; 1996 Mar; 97(3):404-12. PubMed ID: 8604281
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Meningococcal disease and college students. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep; 2000 Jun; 49(RR-7):13-20. PubMed ID: 10902835
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Serogroup B meningococcal vaccines.
    Zimmer SM; Stephens DS
    Curr Opin Investig Drugs; 2006 Aug; 7(8):733-9. PubMed ID: 16955685
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Prospects and challenges with introduction of a mono-valent meningococcal conjugate vaccine in Africa.
    Okoko BJ; Idoko OT; Adegbola RA
    Vaccine; 2009 Mar; 27(14):2023-9. PubMed ID: 19095025
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Quadrivalent meningococcal conjugate vaccines.
    Pace D; Pollard AJ; Messonier NE
    Vaccine; 2009 Jun; 27 Suppl 2():B30-41. PubMed ID: 19477560
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The epidemiology of meningococcal infections in England and Wales, 1912-1983.
    Abbott JD; Jones DM; Painter MJ; Young SE
    J Infect; 1985 Nov; 11(3):241-57. PubMed ID: 3936880
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A review of vaccine research and development: meningococcal disease.
    Girard MP; Preziosi MP; Aguado MT; Kieny MP
    Vaccine; 2006 May; 24(22):4692-700. PubMed ID: 16621189
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Epidemiology and prevention of meningococcal disease.
    Riedo FX; Plikaytis BD; Broome CV
    Pediatr Infect Dis J; 1995 Aug; 14(8):643-57. PubMed ID: 8532420
    [No Abstract]   [Full Text] [Related]  

  • 77. [Invasive meningococcal disease--management and treatment].
    Garlicki A; Bociqga-Jasik M; Kalinowska-Nowak A
    Przegl Epidemiol; 2008; 62 Suppl 1():39-44. PubMed ID: 22320034
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Meningococcal disease in the Israel Defense Force: epidemiologic trends and new challenges.
    Grotto I; Block C; Lerman Y; Wiener M; Ashkenazi S
    Isr J Med Sci; 1995 Jan; 31(1):54-8. PubMed ID: 7836050
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Statement on meningococcal vaccination for travellers. An Advisory Committee Statement (ACS).
    Committee to Advise on Tropical Medicine (CATMAT)
    Can Commun Dis Rep; 2009 Jun; 35(ACS-4):1-22. PubMed ID: 19526652
    [No Abstract]   [Full Text] [Related]  

  • 80. A surveillance network for meningococcal disease in Europe.
    Trotter CL; Chandra M; Cano R; Larrauri A; Ramsay ME; Brehony C; Jolley KA; Maiden MC; Heuberger S; Frosch M
    FEMS Microbiol Rev; 2007 Jan; 31(1):27-36. PubMed ID: 17168995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.